Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-10-20

Clinical Trial Update: 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial for 99m Tc-ANNexin-V-128 scintigraphy in identifying complicated carotid atherosclerotic plaques has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Carotid Atherosclerosis, Atherosclerotic Plaque | Phase 2, Phase 3 | Status: WITHDRAWN